The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

GILEAD SCIENCES, INC.

Reporting owner CIK 0000882095 · 10% owner

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.GILEAD SCIENCES, INC.GILEAD SCIENCES, INC.GILEAD SCIENCES, INC. · November 26, 2025 · Other acquisition · Prefunded Warrants (right to buy)Nov 26, 2025Nov 26, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

1 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 26, 2025Xilio Therapeutics, Inc.Prefunded Warrants (right to buy)GILEAD SCIENCES, INC.Other acquisition

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Xilio Therapeutics, Inc.XLO · company listingsOther acquisitionPrefunded Warrants (right to buy)Derivative security · Code X13,335,0000.7499 *Value: 9,999,916.5Currency not specifiedView ↗